BDX vs CDLX · P/E 34, rev $21.84B vs rev $71.2M
Becton Dickinson and Company (BDX) versus Cardlytics Inc (CDLX) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Cardlytics Inc (CDLX) is a advertising agencies company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported CDLX revenue for 2026-06-30 was $71.2M. Net income was -$19.4M. CDLX currently screens at market cap $95.0M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CDLX currently screens at market cap $95.0M.
Not investment advice. Open the BDX and CDLX stock pages for the full models.
Not investment advice.